Welcome, Guest |
TOPIC:
Immunotherapy in the Treatment of Hepatocellular Carcinoma 7 years 3 months ago #23305
Hopefully this will not be relevant to you, but if you have HCC here is a slide set from Clinical Care Options that outlines the latest advances. Interestingly Incepta in Bangladesh have a range of generic anti cancer agents. As of a week ago.... Nivolumab has not been launched yet but we have launched Erlotinib, Gefitinib and Osimertinib in addition to Adalimumab, Denosumab and Rituximab. While there is not a magic bullet(s) (as yet) it would be possible to used combined therapy with generics that are cost prohibitive otherwise. YMMV | |
Time to create page: 0.059 seconds